WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy

Intrinsic resistance to cytotoxic T-lymphocyte (CTL) killing limits responses to immune activating anti-cancer therapies. Here, we established that activation of the G2/M cell cycle checkpoint results in tumor cell cycle pause and protection from granzyme B-induced cell death. This was reversed with...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncoimmunology
Autori principali: Sun, Lillian, Moore, Ellen, Berman, Rose, Clavijo, Paul E., Saleh, Anthony, Chen, Zhong, Van Waes, Carter, Davies, John, Friedman, Jay, Allen, Clint T.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2018
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6169577/
https://ncbi.nlm.nih.gov/pubmed/30288354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1488359
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi